• Australian (ASX) Stock Market Forum

OSP - Osprey Medical

Discussion in 'Stocks I-P' started by System, Apr 13, 2012.

  1. System

    System Administrator

    Posts:
    1,743
    Likes Received:
    1
    Joined:
    Jun 27, 2010
    Osprey Medical Inc. (OSP) is a medical device company focused on the development and commercialisation of products that are designed to reduce the incidence of contrast induced nephropathy (CIN). The core technology was developed at the Baker IDI Heart and Diabetes Institute in Melbourne by Dr. David Kaye.

    http://www.ospreymed.com
     
  2. piggybank

    piggybank Well-Known Member

    Posts:
    871
    Likes Received:
    0
    Joined:
    Oct 4, 2012
  3. eunice

    eunice New Member

    Posts:
    1
    Likes Received:
    0
    Joined:
    Sep 9, 2015
    OSP - No reduction in CIN disease

    The study of 578 patients, half of which were placebo, showed no reduction in CIN. I read the news release but can't understand how the large sample could be so biased against OSP (due to more sick patients in their group requiring more dye I presume)
     
Loading...

Share This Page